Skip to content

A Contralateral Dispensing Clinical Trial of Study Test Silicone Hydrogel Lens Against Enfilcon A Silicone Hydrogel Lens

A Contralateral Dispensing Clinical Trial of Study Test Silicone Hydrogel Lens Against Enfilcon A Silicone Hydrogel Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02537717
Enrollment
17
Registered
2015-09-02
Start date
2015-10-01
Completion date
2016-04-29
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

This will be a 1-month dispensing, double-masked, randomized, contralateral study comparing the test lens against the control lens. The assignment of lenses to eyes (i.e. which lens type is to be worn in which eye throughout the study) will be selected according to a randomization table.

Detailed description

Both test and control lenses will be used in a daily wear modality for 1 month. It is anticipated that this study will involve the following visits: Baseline (screening and dispense visit combined), 2-week visit and 4-week visit.

Interventions

Each subject randomized to wear either the test or control in either the left of right eye.

Each subject randomized to wear either the test or control in either the left of right eye.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Is at least 17 years of age and has full legal capacity to volunteer * Has read and understood the information consent letter * Is willing and able to follow instructions and maintain the appointment schedule * Is correctable to a visual acuity of 20/30 or better (in each eye) with their habitual correction or the assigned study lenses * Is an adapted soft contact lens wearer (For the purpose of this study: Current lens wear at least 3 days per week, 8 hours each day.)

Exclusion criteria

* Is participating in any concurrent clinical or research study * Has any known active\* ocular disease and/or infection; * Has a systemic condition that in the opinion of the investigator may affect a study outcome variable * Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable\^ * Has known sensitivity to the diagnostic pharmaceuticals to be used in the study * Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit). Rationale is that systemic changes over time due to pregnancy/lactating may adversely affect contact lens wear e.g. ocular dryness may increase. * Is aphakic * Has undergone corneal refractive surgery. For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active. Participants will be excluded with significant slit lamp findings (e.g. infiltrates or other slit lamp findings Grade 3 or above: corneal edema, tarsal abnormalities, and conjunctival injection) or active ocular disease (e.g. glaucoma, history of recurrent corneal erosions, and intraocular infection or inflammation of an allergic, bacterial, or viral etiology). \^ For the purposes of this study, participants will be excluded, if currently taking medication, such as oral antihistamines, antihistamine eye drops, oral and ophthalmic beta-adrenergic blockers (e.g. Propanolol, Timolol), anticholinergics, oral steroids and any prescribed or over-the-counter eye medication, except artificial tears or eye lubricants

Design outcomes

Primary

MeasureTime frameDescription
Subjective Ratings of ComfortBaseline (After 10 minutes of lens dispense)Subjective ratings of Comfort on a scale (0-100) assessed : 0= Cannot be worn, causes pain, 20=Frequently irritating, 40= Occasionally irritating, 60= Occasionally noticable but not irritating, 80= rarely noticeable, 100= cannot be felt ever
Subjective Comfort PreferenceBaseline (after 10 minutes of lens dispense)Subjective comfort preference Sapphire lens, Enfilcon A, no preference
Lens WettabilityBaseline (After 10 minutes of lens dispense)Lens wettability was assessed on a Grading scale (0-4, 0.25 steps) (0=excellent; 4=severely reduced)

Countries

Canada

Participant flow

Participants by arm

ArmCount
Overall Study
Each subject will be randomized to wear the test lens in one eye and control lens in the other eye. Both test and control lenses will be used in a daily wear modality for one month. Sapphire Lens: Contact lens. Enfilcon A: contact lens
17
Total17

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
17 Participants
Age, Continuous28 years
STANDARD_DEVIATION 10
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Canada
17 participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 17
other
Total, other adverse events
0 / 170 / 17
serious
Total, serious adverse events
0 / 170 / 17

Outcome results

Primary

Lens Wettability

Lens wettability was assessed on a Grading scale (0-4, 0.25 steps) (0=excellent; 4=severely reduced)

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Sapphire LensLens Wettability2.9 units on a scaleStandard Deviation 0.9
Enfilcon ALens Wettability2.6 units on a scaleStandard Deviation 1
Primary

Lens Wettability

Lens wettability was assessed on a Grading scale (0-4, 0.25 steps) (0=excellent; 4=severely reduced)

Time frame: Baseline (After 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Sapphire LensLens Wettability2.9 units on a scaleStandard Deviation 0.7
Enfilcon ALens Wettability2.6 units on a scaleStandard Deviation 1
Primary

Lens Wettability

Lens wettability was assessed on a Grading scale (0-4, 0.25 steps) (0=excellent; 4=severely reduced)

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Sapphire LensLens Wettability2.8 units on a scaleStandard Deviation 1
Enfilcon ALens Wettability2.8 units on a scaleStandard Deviation 0.8
Primary

Subjective Comfort Preference

Subjective comfort preference Sapphire lens, Enfilcon A, no preference

Time frame: 2 weeks

ArmMeasureGroupValue (NUMBER)
Sapphire LensSubjective Comfort PreferenceSapphire lens53 percentage of eyes
Sapphire LensSubjective Comfort Preferenceenfilcon A18 percentage of eyes
Sapphire LensSubjective Comfort PreferenceNo preference29 percentage of eyes
Primary

Subjective Comfort Preference

Subjective comfort preference Sapphire lens, Enfilcon A, no preference

Time frame: Baseline (after 10 minutes of lens dispense)

ArmMeasureGroupValue (NUMBER)
Sapphire LensSubjective Comfort PreferenceSapphire lens47 percentage of eyes
Sapphire LensSubjective Comfort Preferenceenfilcon A12 percentage of eyes
Sapphire LensSubjective Comfort PreferenceNo preference41 percentage of eyes
Primary

Subjective Comfort Preference

Subjective comfort preference Sapphire lens, Enfilcon A, no preference

Time frame: 4 weeks

ArmMeasureGroupValue (NUMBER)
Sapphire LensSubjective Comfort PreferenceSapphire lens47 percentage of eyes
Sapphire LensSubjective Comfort Preferenceenfilcon A18 percentage of eyes
Sapphire LensSubjective Comfort PreferenceNo preference35 percentage of eyes
Primary

Subjective Ratings of Comfort

Subjective ratings of Comfort on a scale (0-100) assessed : 0= Cannot be worn, causes pain, 20=Frequently irritating, 40= Occasionally irritating, 60= Occasionally noticable but not irritating, 80= rarely noticeable, 100= cannot be felt ever

Time frame: Baseline (After 10 minutes of lens dispense)

ArmMeasureValue (MEAN)Dispersion
Sapphire LensSubjective Ratings of Comfort92 units on a scaleStandard Deviation 9
Enfilcon ASubjective Ratings of Comfort91 units on a scaleStandard Deviation 9
Primary

Subjective Ratings of Comfort

Subjective ratings of Comfort on a scale (0-100) assessed : 0= Cannot be worn, causes pain, 20=Frequently irritating, 40= Occasionally irritating, 60= Occasionally noticable but not irritating, 80= rarely noticeable, 100= cannot be felt ever

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Sapphire LensSubjective Ratings of Comfort81 units on a scaleStandard Deviation 16
Enfilcon ASubjective Ratings of Comfort80 units on a scaleStandard Deviation 14
Primary

Subjective Ratings of Comfort

Subjective ratings of Comfort on a scale (0-100) assessed : 0= Cannot be worn, causes pain, 20=Frequently irritating, 40= Occasionally irritating, 60= Occasionally noticable but not irritating, 80= rarely noticeable, 100= cannot be felt ever

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Sapphire LensSubjective Ratings of Comfort80 units on a scaleStandard Deviation 18
Enfilcon ASubjective Ratings of Comfort82 units on a scaleStandard Deviation 8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026